Login Register Cart 0
Generic placeholder image

Recent Patents on Anti-Cancer Drug Discovery

Editor-in-Chief

ISSN (Print): 1574-8928
ISSN (Online): 2212-3970

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Regulating Lipid Metabolism via Mitochondrial Dynamics in Tongue Squamous Cell Carcinoma Cancer Stem Cells

Author(s): Fan Wu, Suling Chen, Siqi Ren, Ruixin Wang, Yongmei Tan, Rongxi Chen, Bowen Li*, Haotian Cao* and Jinsong Li*

Volume 20, Issue 3, 2025

Published on: 16 January, 2024

Page: [445 - 459] Pages: 15

DOI: 10.2174/0115748928275772231226063458

Price: $65

Abstract

Background: Cancer stem cells (CSCs) are a sub-population of cancer cells present in many kinds of malignant tumors that have the potential for self-proliferation and differentiation. These cells have been demonstrated as the main cause of tumor recurrence and metastasis. Strong evidence indicates that CSCs prefer reprogrammed fatty acid β-oxidation over oxidative phosphorylation for sustaining energy supply. Although mitochondrial dynamics participate in the regulation of cancer stemness, the correlation between the inhibition of mitochondrial fission and the regulation of lipid metabolism in CSCs remains poorly understood.

Methods: The human tongue squamous cell carcinoma (TSCC) cell lines CAL27 and SAS were used to obtain the CSCs by 3D Spheroid Culture. Then,western blot methods, RT-PCR and flow cytometry analysis were used to identify the TSCC CSCs. Next, Immunofluorescence method, transmission electron microscopy detection and western blot methods were used to evaluate the mitochondrial morphology and the quantity of lipid droplets (LDs). Lastly, lipidomic analysis was applied to explored the lipidomic alterations of TSCC CSCs with different mitochondrial morphology.

Results: Here, we show that the quantity of lipid droplets containing intracellular triglyceride (TG) can be decreased by regulating mitochondrial morphology. Lipidomic analysis using ultraperformance liquid chromatography-mass spectrometry (UPLC-MS) also compared alterations in lipid metabolites in tongue squamous cell carcinoma (TSCC) CSCs, TSCC cells (non-CSCs), and CSCs with different mitochondrial morphology. Discriminant lipids of statistical significance were successfully annotated, including phosphatidylcholines (PCs), phosphatidylethanolamines (PEs), sphingomyelins (SMs), triacylglycerols (TGs), phosphatidylglycerols (PGs), phosphatidylserines (PSs), lysophosphatidylcholines (LPCs), and lysophosphatidylethanolamines (LPEs).

Conclusion: This study provides a deeper insight into the alterations of lipid metabolism associated with TSCC CSCs, non-CSCs and CSCs regulated by mitochondrial dynamics and thus serves as a guide toward novel targeted therapies.

Keywords: Tongue squamous cell carcinoma, cancer stem cells, mitochondrial dynamics, lipid metabolism, lipid droplets, lipid metabolite.

« Previous Next »
[1]
Xia C, Dong X, Li H, et al. Cancer statistics in china and united states, 2022: Profiles, trends, and determinants. Chin Med J 2022; 135(5): 584-90.
[http://dx.doi.org/10.1097/CM9.0000000000002108] [PMID: 35143424]
[2]
Cao M, Shi E, Wang H, et al. Personalized targeted therapeutic strategies against oral squamous cell carcinoma. An evidence-based review of literature. Int J Nanomedicine 2022; 17: 4293-306.
[http://dx.doi.org/10.2147/IJN.S377816] [PMID: 36134201]
[3]
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71(3): 209-49.
[http://dx.doi.org/10.3322/caac.21660] [PMID: 33538338]
[4]
Bera RN, Tandon S, Singh AK, et al. Management and outcome of locally advanced oral squamous cell carcinoma. Natl J Maxillofac Surg 2023; 14(2): 185-9.
[http://dx.doi.org/10.4103/njms.njms_125_22] [PMID: 37661995]
[5]
Almangush A, Mäkitie AA, Triantafyllou A, et al. Staging and grading of oral squamous cell carcinoma: An update. Oral Oncol 2020; 107: 104799.
[http://dx.doi.org/10.1016/j.oraloncology.2020.104799] [PMID: 32446214]
[6]
Bugshan A, Farooq I. Oral squamous cell carcinoma: Metastasis, potentially associated malignant disorders, etiology and recent advancements in diagnosis. F1000 Res 2020; 9: 229.
[http://dx.doi.org/10.12688/f1000research.22941.1] [PMID: 32399208]
[7]
Gibson MK, Li Y, Murphy B, et al. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2005; 23(15): 3562-7.
[http://dx.doi.org/10.1200/JCO.2005.01.057] [PMID: 15908667]
[8]
Gupta AK, McKenna WG, Weber CN, et al. Local recurrence in head and neck cancer: Relationship to radiation resistance and signal transduction. Clin Cancer Res 2002; 8(3): 885-92.
[PMID: 11895923]
[9]
Overgaard J. Hypoxic radiosensitization: Adored and ignored. J Clin Oncol 2007; 25(26): 4066-74.
[http://dx.doi.org/10.1200/JCO.2007.12.7878] [PMID: 17827455]
[10]
Govindasamy R, Venkidasamy B, Thiruvengadam M. Current strategies for overcoming smoking addiction: A major cause of oral cancer. Recent Pat Anticancer Drug Discov 2023.
[11]
Wang C, Li Y, Jia L, et al. CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance. Cell Stem Cell 2021; 28(9): 1597-1613.e7.
[http://dx.doi.org/10.1016/j.stem.2021.04.011] [PMID: 33945793]
[12]
Nowell PC. The clonal evolution of tumor cell populations. Science 1976; 194(4260): 23-8.
[http://dx.doi.org/10.1126/science.959840] [PMID: 959840]
[13]
Shenouda S, Kulkarni K, Abuetabh Y, Sergi C. Cancer stem cells and their management in cancer therapy. Recent Patents Anticancer Drug Discov 2020; 15(3): 212-27.
[http://dx.doi.org/10.2174/1574892815666200713145931] [PMID: 32660407]
[14]
Hittelman WN, Liao Y, Wang L, Milas L. Are cancer stem cells radioresistant? Future Oncol 2010; 6(10): 1563-76.
[http://dx.doi.org/10.2217/fon.10.121] [PMID: 21062156]
[15]
Das M, Law S. Role of tumor microenvironment in cancer stem cell chemoresistance and recurrence. Int J Biochem Cell Biol 2018; 103: 115-24.
[http://dx.doi.org/10.1016/j.biocel.2018.08.011] [PMID: 30153480]
[16]
Li H, Feng Z, He ML. Lipid metabolism alteration contributes to and maintains the properties of cancer stem cells. Theranostics 2020; 10(16): 7053-69.
[http://dx.doi.org/10.7150/thno.41388] [PMID: 32641978]
[17]
Li J, Condello S, Thomes-Pepin J, et al. Lipid desaturation is a metabolic marker and therapeutic target of ovarian cancer stem cells. Cell Stem Cell 2017; 20(3): 303-314.e5.
[http://dx.doi.org/10.1016/j.stem.2016.11.004] [PMID: 28041894]
[18]
Chen CL, Uthaya Kumar DB, Punj V, et al. NANOG metabolically reprograms tumor-initiating stem-like cells through tumorigenic changes in oxidative phosphorylation and fatty acid metabolism. Cell Metab 2016; 23(1): 206-19.
[http://dx.doi.org/10.1016/j.cmet.2015.12.004] [PMID: 26724859]
[19]
Yi M, Li J, Chen S, et al. Emerging role of lipid metabolism alterations in Cancer stem cells. J Exp Clin Cancer Res 2018; 37(1): 118.
[http://dx.doi.org/10.1186/s13046-018-0784-5] [PMID: 29907133]
[20]
Corominas-Faja B, Cuyàs E, Gumuzio J, et al. Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells. Oncotarget 2014; 5(18): 8306-16.
[http://dx.doi.org/10.18632/oncotarget.2059] [PMID: 25246709]
[21]
Giampietri C, Petrungaro S, Cordella M, et al. Lipid storage and autophagy in melanoma cancer cells. Int J Mol Sci 2017; 18(6): 1271.
[http://dx.doi.org/10.3390/ijms18061271] [PMID: 28617309]
[22]
Pascual G, Avgustinova A, Mejetta S, et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature 2017; 541(7635): 41-5.
[http://dx.doi.org/10.1038/nature20791] [PMID: 27974793]
[23]
Rak S, De Zan T, Stefulj J, Kosović M, Gamulin O, Osmak M. FTIR spectroscopy reveals lipid droplets in drug resistant laryngeal carcinoma cells through detection of increased ester vibrational bands intensity. Analyst 2014; 139(13): 3407-15.
[http://dx.doi.org/10.1039/C4AN00412D] [PMID: 24834449]
[24]
Mitra R, Chao O, Urasaki Y, Goodman OB, Le TT. Detection of lipid-rich prostate circulating tumour cells with coherent anti-stokes raman scattering microscopy. BMC Cancer 2012; 12(1): 540-0.
[http://dx.doi.org/10.1186/1471-2407-12-540] [PMID: 23171028]
[25]
Yue S, Li J, Lee SY, et al. Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness. Cell Metab 2014; 19(3): 393-406.
[http://dx.doi.org/10.1016/j.cmet.2014.01.019] [PMID: 24606897]
[26]
Tirinato L, Liberale C, Di Franco S, et al. Lipid droplets: A new player in colorectal cancer stem cells unveiled by spectroscopic imaging. Stem Cells 2015; 33(1): 35-44.
[http://dx.doi.org/10.1002/stem.1837] [PMID: 25186497]
[27]
Archer SL, Longo DL. Mitochondrial dynamics--mitochondrial fission and fusion in human diseases. N Engl J Med 2013; 369(23): 2236-51.
[http://dx.doi.org/10.1056/NEJMra1215233] [PMID: 24304053]
[28]
Xie Q, Wu Q, Horbinski CM, et al. Mitochondrial control by DRP1 in brain tumor initiating cells. Nat Neurosci 2015; 18(4): 501-10.
[http://dx.doi.org/10.1038/nn.3960] [PMID: 25730670]
[29]
Bahat A, Goldman A, Zaltsman Y, et al. MTCH2-mediated mitochondrial fusion drives exit from naïve pluripotency in embryonic stem cells. Nat Commun 2018; 9(1): 5132.
[http://dx.doi.org/10.1038/s41467-018-07519-w] [PMID: 30510213]
[30]
Zhou TJ, Zhang SL, He CY, et al. Downregulation of mitochondrial cyclooxygenase-2 inhibits the stemness of nasopharyngeal carcinoma by decreasing the activity of dynamin-related-protein 1. Theranostics 2017; 7(5): 1389-406.
[http://dx.doi.org/10.7150/thno.17647] [PMID: 28435473]
[31]
Son MY, Choi H, Han YM, Sook Cho Y. Unveiling the critical role of REX1 in the regulation of human stem cell pluripotency. Stem Cells 2013; 31(11): 2374-87.
[http://dx.doi.org/10.1002/stem.1509] [PMID: 23939908]
[32]
Targeting mitochondrial fission through mdivi-1 derivatives. US20210137925A1 2021.
[33]
Rambold AS, Cohen S, Lippincott-Schwartz J. Fatty acid trafficking in starved cells: Regulation by lipid droplet lipolysis, autophagy, and mitochondrial fusion dynamics. Dev Cell 2015; 32(6): 678-92.
[http://dx.doi.org/10.1016/j.devcel.2015.01.029] [PMID: 25752962]
[34]
Kita T, Nishida H, Shibata H, Niimi S, Higuti T, Arakaki N. Possible role of mitochondrial remodelling on cellular triacylglycerol accumulation. J Biochem 2009; 146(6): 787-96.
[http://dx.doi.org/10.1093/jb/mvp124] [PMID: 19671539]
[35]
Su Z, Liu D, Chen L, et al. CD44-targeted magnetic nanoparticles kill head and neck squamous cell carcinoma stem cells in an alternating magnetic field. Int J Nanomedicine 2019; 14: 7549-60.
[http://dx.doi.org/10.2147/IJN.S215087] [PMID: 31571863]
[36]
Lim YC, Oh SY, Cha YY, Kim SH, Jin X, Kim H. Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas. Oral Oncol 2011; 47(2): 83-91.
[http://dx.doi.org/10.1016/j.oraloncology.2010.11.011] [PMID: 21167769]
[37]
Qiu X, Wang Z, Li Y, Miao Y, Ren Y, Luan Y. Characterization of sphere-forming cells with stem-like properties from the small cell lung cancer cell line H446. Cancer Lett 2012; 323(2): 161-70.
[http://dx.doi.org/10.1016/j.canlet.2012.04.004] [PMID: 22521544]
[38]
Gibbs CP, Kukekov VG, Reith JD, et al. Stem-like cells in bone sarcomas: Implications for tumorigenesis. Neoplasia 2005; 7(11): 967-76.
[http://dx.doi.org/10.1593/neo.05394] [PMID: 16331882]
[39]
Wang L, Mezencev R, Bowen NJ, Matyunina LV, McDonald JF. Isolation and characterization of stem-like cells from a human ovarian cancer cell line. Mol Cell Biochem 2012; 363(1-2): 257-68.
[http://dx.doi.org/10.1007/s11010-011-1178-6] [PMID: 22160925]
[40]
Dattilo R, et al. Pyrvinium pamoate induces death of triple-negative breast cancer stem-like cells and reduces metastases through effects on lipid anabolism.In: Cancer Research. 2019; p. 1184.
[41]
Cianciosi D, Forbes-Hernández TY, Ansary J, et al. Phenolic compounds from Mediterranean foods as nutraceutical tools for the prevention of cancer: The effect of honey polyphenols on colorectal cancer stem-like cells from spheroids. Food Chem 2020; 325: 126881.
[http://dx.doi.org/10.1016/j.foodchem.2020.126881] [PMID: 32387951]
[42]
Wang X, Zhou W, Li X, et al. Graphene oxide suppresses the growth and malignancy of glioblastoma stem cell-like spheroids via epigenetic mechanisms. J Transl Med 2020; 18(1): 200.
[http://dx.doi.org/10.1186/s12967-020-02359-z] [PMID: 32410622]
[43]
Zhao X, Ma L, Dai L, et al. TNF α promotes the malignant transformation of intestinal stem cells through the NF κB and Wnt/β catenin signaling pathways. Oncol Rep 2020; 44(2): 577-88.
[http://dx.doi.org/10.3892/or.2020.7631] [PMID: 32627006]
[44]
Lin J, Yoon C, Li P, et al. CDK5RAP3 as tumour suppressor negatively regulates self-renewal and invasion and is regulated by ERK1/2 signalling in human gastric cancer. Br J Cancer 2020; 123(7): 1131-44.
[http://dx.doi.org/10.1038/s41416-020-0963-y] [PMID: 32606358]
[45]
Wang JX, Jiao JQ, Li Q, et al. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat Med 2011; 17(1): 71-8.
[http://dx.doi.org/10.1038/nm.2282] [PMID: 21186368]
[46]
Kerk SA, Finkel KA, Pearson AT, et al. 5T4-targeted therapy ablates cancer stem cells and prevents recurrence of head and neck squamous cell carcinoma. Clin Cancer Res 2017; 23(10): 2516-27.
[http://dx.doi.org/10.1158/1078-0432.CCR-16-1834] [PMID: 27780858]
[47]
Krishnamurthy S, Dong Z, Vodopyanov D, et al. Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. Cancer Res 2010; 70(23): 9969-78.
[http://dx.doi.org/10.1158/0008-5472.CAN-10-1712] [PMID: 21098716]
[48]
Clay MR, Tabor M, Owen JH, et al. Single‐marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck 2010; 32(9): 1195-201.
[http://dx.doi.org/10.1002/hed.21315] [PMID: 20073073]
[49]
Qi W, Fitchev PS, Cornwell ML, et al. FOXO3 growth inhibition of colonic cells is dependent on intraepithelial lipid droplet density. J Biol Chem 2013; 288(23): 16274-81.
[http://dx.doi.org/10.1074/jbc.M113.470617] [PMID: 23603907]
[50]
Cotte AK, Aires V, Fredon M, et al. Lysophosphatidylcholine acyltransferase 2-mediated lipid droplet production supports colorectal cancer chemoresistance. Nat Commun 2018; 9(1): 322.
[http://dx.doi.org/10.1038/s41467-017-02732-5] [PMID: 29358673]
[51]
Bosch M, Sánchez-Álvarez M, Fajardo A, et al. Mammalian lipid droplets are innate immune hubs integrating cell metabolism and host defense. Science 2020; 370(6514): eaay8085.
[http://dx.doi.org/10.1126/science.aay8085] [PMID: 33060333]
[52]
Igal RA. Stearoyl CoA desaturase-1: New insights into a central regulator of cancer metabolism. Biochim Biophys Acta Mol Cell Biol Lipids 2016; 1861(12): 1865-80.
[http://dx.doi.org/10.1016/j.bbalip.2016.09.009] [PMID: 27639967]
[53]
Pandey PR, Xing F, Sharma S, et al. Elevated lipogenesis in epithelial stem-like cell confers survival advantage in ductal carcinoma in situ of breast cancer. Oncogene 2013; 32(42): 5111-22.
[http://dx.doi.org/10.1038/onc.2012.519] [PMID: 23208501]
[54]
Brandi J, Dando I, Pozza ED, et al. Proteomic analysis of pancreatic cancer stem cells: Functional role of fatty acid synthesis and mevalonate pathways. J Proteomics 2017; 150: 310-22.
[http://dx.doi.org/10.1016/j.jprot.2016.10.002] [PMID: 27746256]
[55]
Tan Z, Xiao L, Tang M, et al. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy. Theranostics 2018; 8(9): 2329-47.
[http://dx.doi.org/10.7150/thno.21451] [PMID: 29721083]
[56]
Hale JS, Otvos B, Sinyuk M, et al. Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression. Stem Cells 2014; 32(7): 1746-58.
[http://dx.doi.org/10.1002/stem.1716] [PMID: 24737733]
[57]
Wang CW. Lipid droplets, lipophagy, and beyond. Biochim Biophys Acta Mol Cell Biol Lipids 2016; 1861(8): 793-805.
[http://dx.doi.org/10.1016/j.bbalip.2015.12.010] [PMID: 26713677]
[58]
Hultsch S, Kankainen M, Paavolainen L, et al. Association of tamoxifen resistance and lipid reprogramming in breast cancer. BMC Cancer 2018; 18(1): 850.
[http://dx.doi.org/10.1186/s12885-018-4757-z] [PMID: 30143015]
[59]
Lee HJ, Li J, Vickman RE, et al. Cholesterol esterification inhibition suppresses prostate cancer metastasis by impairing the wnt/β-catenin pathway. Mol Cancer Res 2018; 16(6): 974-85.
[http://dx.doi.org/10.1158/1541-7786.MCR-17-0665] [PMID: 29545473]
[60]
Senkal CE, Salama MF, Snider AJ, et al. Ceramide is metabolized to acylceramide and stored in lipid droplets. Cell Metab 2017; 25(3): 686-97.
[http://dx.doi.org/10.1016/j.cmet.2017.02.010] [PMID: 28273483]
[61]
Cruz ALS, Barreto EA, Fazolini NPB, Viola JPB, Bozza PT. Lipid droplets: Platforms with multiple functions in cancer hallmarks. Cell Death Dis 2020; 11(2): 105.
[http://dx.doi.org/10.1038/s41419-020-2297-3] [PMID: 32029741]
[62]
McIntosh AL, Storey SM, Atshaves BP. Intracellular lipid droplets contain dynamic pools of sphingomyelin: ADRP binds phospholipids with high affinity. Lipids 2010; 45(6): 465-77.
[http://dx.doi.org/10.1007/s11745-010-3424-1] [PMID: 20473576]
[63]
Blouin CM, Le Lay S, Eberl A, et al. Lipid droplet analysis in caveolin-deficient adipocytes: alterations in surface phospholipid composition and maturation defects. J Lipid Res 2010; 51(5): 945-56.
[http://dx.doi.org/10.1194/jlr.M001016] [PMID: 19965594]
[64]
El-Hafidi M, Correa F, Zazueta C. Mitochondrial dysfunction in metabolic and cardiovascular diseases associated with cardiolipin remodeling. Biochim Biophys Acta Mol Basis Dis 2020; 1866(6): 165744.
[http://dx.doi.org/10.1016/j.bbadis.2020.165744] [PMID: 32105822]
[65]
Kiebish MA, Han X, Cheng H, Chuang JH, Seyfried TN. Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer. J Lipid Res 2008; 49(12): 2545-56.
[http://dx.doi.org/10.1194/jlr.M800319-JLR200] [PMID: 18703489]
[66]
Terao M, Goracci L, Celestini V, et al. Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid. J Exp Clin Cancer Res 2019; 38(1): 436.
[http://dx.doi.org/10.1186/s13046-019-1438-y]
[67]
Deshmukh A, Deshpande K, Arfuso F, Newsholme P, Dharmarajan A. Cancer stem cell metabolism: A potential target for cancer therapy. Mol Cancer 2016; 15(1): 69-9.
[http://dx.doi.org/10.1186/s12943-016-0555-x] [PMID: 27825361]
[68]
Nair S, Sobotka KS, Joshi P, et al. Lipopolysaccharide‐induced alteration of mitochondrial morphology induces a metabolic shift in microglia modulating the inflammatory response in vitro and in vivo. Glia 2019; 67(6): 1047-61.
[http://dx.doi.org/10.1002/glia.23587] [PMID: 30637805]
[69]
Hoque A, Sivakumaran P, Bond ST, et al. Mitochondrial fission protein Drp1 inhibition promotes cardiac mesodermal differentiation of human pluripotent stem cells. Cell Death Discov 2018; 4(1): 39.
[http://dx.doi.org/10.1038/s41420-018-0042-9] [PMID: 29531836]
[70]
Tran Q, Jung JH, Park J, et al. S6 kinase 1 plays a key role in mitochondrial morphology and cellular energy flow. Cell Signal 2018; 48: 13-24.
[http://dx.doi.org/10.1016/j.cellsig.2018.04.002] [PMID: 29673648]
[71]
Penno A, Hackenbroich G, Thiele C. Phospholipids and lipid droplets. Biochim Biophys Acta Mol Cell Biol Lipids 2013; 1831(3): 589-94.
[http://dx.doi.org/10.1016/j.bbalip.2012.12.001]
[72]
Hoffmann PR, deCathelineau AM, Ogden CA, et al. Phosphatidylserine (PS) induces PS receptor–mediated macropinocytosis and promotes clearance of apoptotic cells. J Cell Biol 2001; 155(4): 649-60.
[http://dx.doi.org/10.1083/jcb.200108080] [PMID: 11706053]
[73]
Seneviratne AK, Xu M, Henao JJA, et al. The mitochondrial transacylase, tafazzin, regulates aml stemness by modulating intracellular levels of phospholipids. Cell Stem Cell 2019; 24(4): 621-636.e16.
[http://dx.doi.org/10.1016/j.stem.2019.02.020] [PMID: 30930145]
[74]
Xu C, Zheng Z, Fang L, et al. Phosphatidylserine enhances osteogenic differentiation in human mesenchymal stem cells via ERK signal pathways. Mater Sci Eng C 2013; 33(3): 1783-8.
[http://dx.doi.org/10.1016/j.msec.2013.01.005] [PMID: 23827636]
[75]
Keckesova Z, Donaher JL, De Cock J, et al. LACTB is a tumour suppressor that modulates lipid metabolism and cell state. Nature 2017; 543(7647): 681-6.
[http://dx.doi.org/10.1038/nature21408] [PMID: 28329758]
[76]
Tasseva G, Bai HD, Davidescu M, Haromy A, Michelakis E, Vance JE. Phosphatidylethanolamine deficiency in mammalian mitochondria impairs oxidative phosphorylation and alters mitochondrial morphology. J Biol Chem 2013; 288(6): 4158-73.
[http://dx.doi.org/10.1074/jbc.M112.434183] [PMID: 23250747]
[77]
Riekhof WR, Voelker DR. Uptake and utilization of lyso-phosphatidylethanolamine by Saccharomyces cerevisiae. J Biol Chem 2006; 281(48): 36588-96.
[http://dx.doi.org/10.1074/jbc.M608851200] [PMID: 17015438]
[78]
Aoki J, Taira A, Takanezawa Y, et al. Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J Biol Chem 2002; 277(50): 48737-44.
[http://dx.doi.org/10.1074/jbc.M206812200] [PMID: 12354767]
[79]
Jonas A. Lecithin cholesterol acyltransferase. Biochim Biophys Acta Mol Cell Biol Lipids 2000; 1529(1-3): 245-56.
[http://dx.doi.org/10.1016/S1388-1981(00)00153-0]

Rights & Permissions Print Cite
Article Metrics
28
1
Wayfinder Image
© 2026 Bentham Science Publishers | Privacy Policy